Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Philippe Millet

Has grant

Biophysicist

University Hospital of Geneva

Switzerland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Switzerland

Recent Grants

Grant: Close

Interplay between APOE polymorphism and glial function in Alzheimer’s disease

Open Date: 2026-04-01

Close Date:

Grant: Open

Overcoming BBB with low- intensity ultrasound for CAR-T cell therapy of glioblastoma

Open Date: 2025-09-01

Close Date: 2028-09-01

Grant: Close

Molecular Imaging of Neuroinflammation in Bipolar Disorder: a Translational Validation of the TSPO Quantification Methodology

Open Date: 2020-01-01

Close Date: 2023-12-31

Grant: Close

Studying the neurochemical determinants of antipsychotic efficacy and side effect profile: a translational dopamine D2 and serotonin 2A receptor neuroimaging approach

Open Date: 2015-02-01

Close Date: 2018-01-31

Grant: Close

Effects of a subchronic treatment with Delta9-tetrahydrocannabinol (THC) on behavior and in vivo dopamine function: a positron emission tomography study in rats

Open Date: 2009-03-01

Close Date: 2013-05-31

Articles (18)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (14)

Herve Boutin

The University of Manchester

UNITED KINGDOM

View details

Sandrine Bacot

Université Grenoble Alpes

FRANCE

View details

Luke Michael Healy

CANADA

View details

Anna Barron

Assistant Professor

Nanyang Technological University (NTU)

SINGAPORE

View details

Amy Smith

Senior Research Fellow

University of Auckland

NEW ZEALAND

View details

Kelly Ceyzériat

Research and teaching fellow

University of Geneva

SWITZERLAND

View details

Ingo Schiessl

The University of Manchester

UNITED KINGDOM

View details

Aurelien Lathuiliere

Group Leader & Privat Docent

University of Geneva

SWITZERLAND

View details

Jean-Luc Lenormand

Professor

Université Grenoble Alpes

FRANCE

View details

Hannes Kaddatz

University of Rostock

GERMANY

View details

Stergios Tsartsalis

SNSF Ambizione Lecturer

University Hospital of Geneva

SWITZERLAND

View details

Benjamin B Tournier

Research Scientist

University Hospital of Geneva

SWITZERLAND

View details

Owain W. Howell

UNITED KINGDOM

View details

David Owen

Imperial College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Philippe Millet

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (18)

Chemogenetic activation of oxytocinergic neurons modulates acute neuroinflammation and improves brain development after pediatric traumatic brain injury

Early metabolic changes in the brain of Alzheimer’s disease rats are driven by GLAST+ cells

Fecal Microbiota Transplantation (FMT) From a Human at Low Risk for Alzheimer's Disease Improves Short-Term Recognition Memory and Increases Neuroinflammation in a 3xTg AD Mouse Model.

TSPO contributes to neuropathology and cognitive deficits in Alzheimer’s disease

Non-linear microglial, inflammatory and oligodendrocyte dynamics across stages of Alzheimer's disease

Radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans

Stools from a human APOEe2 donor reduces amyloid and tau pathology and increases neuroinflammation in a 3xTg AD mouse model.

Glial cells are involved in day-night protein dysregulation in the hippocampus of a mouse model of Alzheimer's disease.

Brain, CSF, and Blood Metabolomics Signature in the TgF344-AD Rat Model of Alzheimer's Disease.

Impairment of hippocampal astrocyte-mediated striatal dopamine release and locomotion in Alzheimer's disease

Brain and plasmatic <scp>CLUSTERIN</scp> are translational markers of <scp>Alzheimer's</scp> disease

A single-domain antibody for the detection of pathological Tau protein in the early stages of oligomerization

Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease.

Low-Dose Radiation Therapy Impacts Microglial Inflammatory Response without Modulating Amyloid Load in Female TgF344-AD Rats.

Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases

18 kDa Translocator Protein TSPO Is a Mediator of Astrocyte Reactivity.

Reactive astrocytes mediate TSPO overexpression in response to sustained CNTF exposure in the rat striatum

Low-molecular weight sulfated marine polysaccharides: Promising molecules to prevent neurodegeneration in mucopolysaccharidosis IIIA?

Collaborators (14)

Herve Boutin

Sandrine Bacot

Luke Michael Healy

Anna Barron

Amy Smith

Kelly Ceyzériat

Ingo Schiessl

Aurelien Lathuiliere

Jean-Luc Lenormand

Hannes Kaddatz

Stergios Tsartsalis

Benjamin B Tournier

Owain W. Howell

David Owen

Make your next move.

Philippe Millet

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (18)

Chemogenetic activation of oxytocinergic neurons modulates acute neuroinflammation and improves brain development after pediatric traumatic brain injury

Early metabolic changes in the brain of Alzheimer’s disease rats are driven by GLAST+ cells

Fecal Microbiota Transplantation (FMT) From a Human at Low Risk for Alzheimer's Disease Improves Short-Term Recognition Memory and Increases Neuroinflammation in a 3xTg AD Mouse Model.

TSPO contributes to neuropathology and cognitive deficits in Alzheimer’s disease

Non-linear microglial, inflammatory and oligodendrocyte dynamics across stages of Alzheimer's disease

Radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans

Stools from a human APOEe2 donor reduces amyloid and tau pathology and increases neuroinflammation in a 3xTg AD mouse model.

Glial cells are involved in day-night protein dysregulation in the hippocampus of a mouse model of Alzheimer's disease.

Brain, CSF, and Blood Metabolomics Signature in the TgF344-AD Rat Model of Alzheimer's Disease.

Impairment of hippocampal astrocyte-mediated striatal dopamine release and locomotion in Alzheimer's disease

Brain and plasmatic <scp>CLUSTERIN</scp> are translational markers of <scp>Alzheimer's</scp> disease

A single-domain antibody for the detection of pathological Tau protein in the early stages of oligomerization

Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease.

Low-Dose Radiation Therapy Impacts Microglial Inflammatory Response without Modulating Amyloid Load in Female TgF344-AD Rats.

Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases

18 kDa Translocator Protein TSPO Is a Mediator of Astrocyte Reactivity.

Reactive astrocytes mediate TSPO overexpression in response to sustained CNTF exposure in the rat striatum

Low-molecular weight sulfated marine polysaccharides: Promising molecules to prevent neurodegeneration in mucopolysaccharidosis IIIA?

Collaborators (14)

Herve Boutin

Sandrine Bacot

Luke Michael Healy

Anna Barron

Amy Smith

Kelly Ceyzériat

Ingo Schiessl

Aurelien Lathuiliere

Jean-Luc Lenormand

Hannes Kaddatz

Stergios Tsartsalis

Benjamin B Tournier

Owain W. Howell

David Owen

Make your next move.

Radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans